A randomized phase II trial comparing capecitabine with oxaliplatin or docetaxel as first-line treatment in advanced gastric and gastroesophageal adenocarcinomas

BACKGROUND: A combination of fluoropyrimidines and platinum is widely accepted as the standard first-line treatment for advanced gastric and gastroesophageal adenocarcinomas. However, the benefit compared with platinum-free chemotherapeutic regimens remains controversial. We compared the efficacy an...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Medicine (Baltimore)
Autori principali: Ni, Lu, Zhang, Weihan, Chen, Ye, Leng, Weibing, Gou, Hongfeng, Hu, Jiankun, Qiu, Meng
Natura: Artigo
Lingua:Inglês
Pubblicazione: Lippincott Williams & Wilkins 2021
Soggetti:
5700
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8084035/
https://ncbi.nlm.nih.gov/pubmed/33907099
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000025493
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi